All Stories

  1. Molecular Insights into Bismuth’s New Applications against Antimicrobial Resistance and Coronaviruses
  2. The metallome and the biological periodic table: A metal atlas in cells
  3. Au(I)-based compounds inhibit nsp14/nsp10 and nsp13 (helicase) to exert anti-SARS-CoV-2 properties
  4. Metal-modulated T cell antitumor immunity and emerging metalloimmunotherapy
  5. Metal-Based Approaches for the Fight against Antimicrobial Resistance: Mechanisms, Opportunities, and Challenges
  6. Hinokitiol potentiates antimicrobial activity of bismuth drugs: a combination therapy for overcoming antimicrobial resistance
  7. Bismuth drug eradicates multi-drug resistant Burkholderia cepacia complex via aerobic respiration
  8. Unprecedented allosteric inhibition of E. coli malate dehydrogenase by silver(i) from atomic resolution analysis
  9. Lighting Up and Identifying Metal-Binding Proteins in Cells
  10. Bismuth-based drugs sensitize Pseudomonas aeruginosa to multiple antibiotics by disrupting iron homeostasis
  11. Integration of metalloproteome and immunoproteome reveals a tight link of iron-related proteins with COVID-19 pathogenesis and immunity
  12. Protein-templated ligand discovery via the selection of DNA-encoded dynamic libraries
  13. Copper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase
  14. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model
  15. Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase
  16. Metal-detection based techniques and their applications in metallobiology
  17. Introduction to “Chemical biology of metals”
  18. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex
  19. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
  20. Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
  21. Metalloproteomics
  22. Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stress
  23. Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms
  24. Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
  25. A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases
  26. Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection
  27. Metallomics and metalloproteomics
  28. Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity
  29. Metal Complexes as Resistance Breakers or Metalloantibiotics for Combating Antimicrobial Resistance
  30. Computed Tomography of Cartilage: An Exploration of Novel Cationic Bismuth Contrast Agent
  31. Binding of ruthenium and osmium at non‑iron sites of transferrin accounts for their iron-independent cellular uptake
  32. An ensemble 3D deep-learning model to predict protein metal-binding site
  33. Metalloproteomics for Biomedical Research: Methodology and Applications
  34. Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
  35. Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation
  36. A hydroxide lock for metallo-β-lactamases
  37. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
  38. Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
  39. Metal-based strategies for the fight against COVID-19
  40. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL
  41. Eradication of Porphyromonas gingivalis Persisters Through Colloidal Bismuth Subcitrate Synergistically Combined With Metronidazole
  42. Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  43. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  44. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
  45. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
  46. A. Sigel, E. Freisinger & R. K. O. Sigel (Eds.), M. E. Sosa Torres & P. M. H. Kroneck (volume Eds.): Transition Metals and Sulfur – A Strong Relationship for Life
  47. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
  48. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
  49. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
  50. Bismuth—The Magic Element
  51. Atomic differentiation of silver binding preference in protein targets:Escherichia colimalate dehydrogenase as a paradigm
  52. Bismuth drugs as antimicrobial agents
  53. Predicting disease-associated mutation of metal-binding sites in proteins using a deep learning approach
  54. Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli
  55. Recognition of Proteins by Metal Chelation-Based Fluorescent Probes in Cells
  56. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
  57. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
  58. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells
  59. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping
  60. A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
  61. Green Fluorescent Probe for Imaging His6-Tagged Proteins Inside Living Cells
  62. MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers
  63. Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli
  64. Bismuth: Environmental Pollution and Health Effects
  65. Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
  66. S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells
  67. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
  68. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
  69. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum
  70. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
  71. Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
  72. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism inHelicobacter pylorion bismuth treatment
  73. Tracking iron-associated proteomes in pathogens by a fluorescence approach
  74. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival
  75. A Ni-NTA-based red fluorescence probe for protein labelling in live cells
  76. Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags
  77. Identification of catabolite control protein A fromStaphylococcus aureusas a target of silver ions
  78. Integration of fluorescence imaging with proteomics enables visualization and identification of metallo-proteomes in living cells
  79. Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
  80. Exploration into the nickel ‘microcosmos’ in prokaryotes
  81. UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori
  82. Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
  83. Rapid labeling of intracellular His-tagged proteins in living cells
  84. Loss of APD1 in Yeast Confers Hydroxyurea Sensitivity Suppressed by Yap1p Transcription Factor
  85. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs
  86. “Anion clamp” allows flexible protein to impose coordination geometry on metal ions
  87. On-line coupling of continuous-flow gel electrophoresis with inductively coupled plasma-mass spectrometry to quantitatively evaluate intracellular metal binding properties of metallochaperones HpHypA and HpHspA in E. coli cells
  88. Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography
  89. Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET
  90. Antimony and Bismuth
  91. Structure of RPA32 bound to the N‐terminus of SMARCAL1 redefines the binding interface between RPA32 and its interacting proteins
  92. Urease inactivation by an unusual GroES chaperonin
  93. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth
  94. In-cell NMR: an emerging approach for monitoring metal-related events in living cells
  95. Size-tunable fabrication of multifunctional Bi2O3 porous nanospheres for photocatalysis, bacteria inactivation and template-synthesis
  96. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori
  97. BiOX (X=Cl, Br, I) nanostructures: Mannitol-mediated microwave synthesis, visible light photocatalytic performance, and Cr(VI) removal capacity
  98. Identification of Metal‐Associated Proteins in Cells by Using Continuous‐Flow Gel Electrophoresis and Inductively Coupled Plasma Mass Spectrometry
  99. ChemInform Abstract: Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment.
  100. Tunable BiOCl hierarchical nanostructures for high-efficient photocatalysis under visible light irradiation
  101. Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1
  102. Binding of oxo-Cu2 clusters to ferric ion-binding protein A from Neisseria gonorrhoeae: a structural insight
  103. Histidine-rich proteins in prokaryotes: metal homeostasis and environmental habitat-related occurrence
  104. Interaction of SlyD with HypB of Helicobacter pylori facilitates nickel trafficking
  105. Structure-oriented bioinformatic approach exploring histidine-rich clusters in proteins
  106. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
  107. Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment
  108. Metallomics in environmental and health related research: Current status and perspectives
  109. Facile Microwave Synthesis of 3D Flowerlike BiOBr Nanostructures and Their Excellent CrVI Removal Capacity
  110. Recent advances in bioinorganic chemistry of bismuth
  111. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
  112. Covalently linking the Escherichia coli global anaerobic regulator FNR in tandem allows it to function as an oxygen stable dimer
  113. Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA
  114. Large-scale synthesis of bismuth hollow nanospheres for highly efficient Cr(vi) removal
  115. Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
  116. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
  117. Probing of bismuth antiulcer drug targets in H. pylori by laser ablation-inductively coupled plasma mass spectrometry
  118. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation
  119. Microwave synthesis of BiPO4 nanostructures and their morphology-dependent photocatalytic performances
  120. Assembly of Preactivation Complex for Urease Maturation inHelicobacter pylori
  121. Histidine-rich protein Hpn from Helicobacter pylori forms amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells
  122. Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
  123. Metal‐Binding Properties of an Hpn‐Like Histidine‐Rich Protein
  124. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  125. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  126. NMR Studies of Metalloproteins
  127. Biological Chemistry of Arsenic, Antimony and Bismuth
  128. Biological Chemistry of Antimony and Bismuth
  129. Metalloproteomics of Arsenic, Antimony and Bismuth Based Drugs
  130. Polymeric architectures of bismuth citrate based on dimeric building blocks
  131. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization
  132. Iron-containing lipoprotein SiaA in SiaABC, the primary heme transporter of Streptococcus pyogenes
  133. Nuclear-based Metallomics in Metal-based Drugs
  134. Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties
  135. A new capillary electrophoresis buffer for determining organic and inorganic anions in electroplating bath with surfactant additives
  136. A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
  137. A biomimetic zinc activated ion channel
  138. Metallomics: An integrated science for metals in biology and medicine
  139. Metallomics: An integrated biometal science
  140. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
  141. Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex
  142. Structure of a Nickel Chaperone, HypA, from Helicobacter pylori Reveals Two Distinct Metal Binding Sites
  143. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2
  144. The structural and biological significance of the EAAEAE insert in the α-domain of human neuronal growth inhibitory factor
  145. Crystal Structure and Metal Binding Properties of the Lipoprotein MtsA, Responsible for Iron Transport in Streptococcus pyogenes
  146. Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes
  147. Important roles of the conserved linker-KKS in human neuronal growth inhibitory factor
  148. Identification and characterization of metallodrug binding proteins by (metallo)proteomics
  149. Editorial and Advisory Board profiles
  150. Identification of Proteins Related to Nickel Homeostasis in Helicobater pylori by Immobilized Metal Affinity Chromatography and Two-Dimensional Gel Electrophoresis
  151. Study on structure–property–reactivity–function relationship of human neuronal growth inhibitory factor (hGIF)
  152. Binding of Ni2+ to a histidine- and glutamine-rich protein, Hpn-like
  153. Structure, topology and assembly of a 32-mer peptide corresponding to the loop 3 and transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  154. A Histidine-rich and Cysteine-rich Metal-binding Domain at the C Terminus of Heat Shock Protein A from Helicobacter pylori
  155. Lipoprotein MtsA of MtsABC in Streptococcus pyogenes primarily binds ferrous ion with bicarbonate as a synergistic anion
  156. Double-strand DNA cleavage by copper complexes of 2,2′-dipyridyl with guanidinium/ammonium pendants
  157. The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein
  158. Biocoordination chemistry of bismuth: Recent advances
  159. Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor
  160. Bismuth Complexes Inhibit the SARS Coronavirus
  161. Bismuth Complexes Inhibit the SARS Coronavirus
  162. Bioinorganic Chemistry of Bismuth and Antimony: Target Sites of Metallodrugs
  163. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
  164. Solution structures, dynamics, and lipid‐binding of the sterile α‐motif domain of the deleted in liver cancer 2
  165. Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation
  166. Metallodrugs
  167. An Effective Metallohydrolase Model with a Supramolecular Environment: Structures, Properties, and Activities
  168. Bioinorganic Chemistry of Bismuth and Antimony:  Target Sites of Metallodrugs
  169. Silver nanoparticles: partial oxidation and antibacterial activities
  170. Synthesis, Structure, and Activity of Supramolecular Mimics for the Active Site and Arg141 Residue of Copper, Zinc−Superoxide Dismutase
  171. Encapsulation of platinum anticancer drugs by apoferritin
  172. Inhibition of SARS coronavirus helicase by bismuth complexes
  173. Cleavage of double-strand DNA by zinc complexes of dicationic 2,2′-dipyridyl derivatives
  174. Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
  175. Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugs
  176. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3
  177. Thermodynamic and Kinetic Aspects of Metal Binding to the Histidine-rich Protein, Hpn
  178. The role of Thr5 in human neuron growth inhibitory factor
  179. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
  180. Solution structure and dynamics of human metallothionein‐3 (MT‐3)
  181. HFIP‐induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
  182. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate
  183. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni 2+ storage in Helicobacter pylori
  184. Complexation of antimony (SbV) with guanosine 5′-monophosphate and guanosine 5′-diphospho-d-mannose: Formation of both mono- and bis-adducts
  185. An Insight of S-Nitrosylation of Human GIF
  186. The Stepwise Process of Chromium-Induced DNA Breakage:  Characterization by Electrochemistry, Atomic Force Microscopy, and DNA Electrophoresis
  187. Transferrin-Mediated Gold Nanoparticle Cellular Uptake
  188. 51 Sb Antimony in Medicine
  189. NMR structures and orientation of the fourth transmembrane domain of the rat divalent metal transporter (DMT1) with G185D mutation in SDS micelles
  190. Structure, Assembly, and Topology of the G185R Mutant of the Fourth Transmembrane Domain of Divalent Metal Transporter
  191. Controlled synthesis of high crystalline bismuth sulfide nanorods: using bismuth citrate as a precursor
  192. In Vitro Inhibition of Human Immunodeficiency Virus Type‐1 (HIV‐1) Reverse Transcriptase by Gold(III) Porphyrins
  193. Dynamic and Kinetic Aspects of Metallodrugs by NMR
  194. The low pKa value of iron‐binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin
  195. Inhibition of alcohol dehydrogenase by bismuth☆
  196. Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane‐mimetic environments
  197. Bismuth in Medicine
  198. DNA hydrolysis promoted by di- and multi-nuclear metal complexes
  199. The effect of the EAAEAE insert on the property of human metallothionein-3
  200. Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)
  201. Recognition of antimony and bismuth by peptides and proteins: insight into the mechanism of action
  202. Three dimensional structures and topology of the transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  203. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
  204. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter
  205. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma
  206. Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details...
  207. An oscillating C22? unit inside a copper rectangleElectronic supplementary information (ESI) available: NMR spectra and computational details. See http://www.rsc.org/suppdata/cc/b3/b301842c/
  208. Helicases as antiviral drug targets
  209. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activationElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b2/b210240d/
  210. Complexation of ytterbium to human transferrin and its uptake by K562 cells
  211. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
  212. Stereo- and Enantioselective Alkene Epoxidations: A Comparative Study of D4- and D2-Symmetric Homochiral trans-Dioxoruthenium(VI) Porphyrins
  213. The role of the transferrin–transferrin-receptor system in drug delivery and targeting
  214. Interactions of Bismuth with Human Lactoferrin and Recognition of the BiIII−Lactoferrin Complex by Intestinal Cells
  215. Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
  216. Intracellular Sb-trypanothione
  217. Complexation of Antimony(III) by Trypanothione
  218. Interaction of antimony tartrate with the tripeptide glutathione
  219. TiIV Uptake and Release by Human Serum Transferrin and Recognition of TiIV-Transferrin by Cancer Cells:  Understanding the Mechanism of Action of the Anticancer Drug Titanocene Dichloride
  220. Stereoselective Formation of Seven-Coordinate Titanium(IV) Monomer and Dimer Complexes of Ethylenebis(o-hydroxyphenyl)glycine
  221. ChemInform Abstract: Transferrin as a Metal Ion Mediator
  222. Interactions of Bismuth Complexes with Metallothionein(II)
  223. Transferrin as a Metal Ion Mediator
  224. Coordination chemistry of metals in medicine: target sites for bismuth
  225. Bismuth Antiulcer Complexes
  226. N-lobe versus C-lobe complexation of bismuth by human transferrin
  227. Coordination of Zn2+ (and Cd2+) by Prokaryotic Metallothionein
  228. The First Specific TiIV-Protein Complex: Potential Relevance to Anticancer Activity of Titanocenes
  229. [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions
  230. New approach to the solution chemistry of bismuth citrate antiulcer complexes
  231. The Biological and Medicinal Chemistry of Bismuth
  232. Determination of Bismuth in Serum Urine by Direct Injection Nebulization Inductively Coupled Plasma Mass Spectrometry
  233. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
  234. Rationalization of the Strength of Metal Binding to Human Serum Transferrin
  235. Molecular assemblies of diazafluorenone Schiff-base amphiphiles. III.13C NMR investigations of reversed micelles in deuteriochloroform
  236. Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly)
  237. Solid-state carbon-13 nuclear magnetic resonance investigations of bismuth citrate complexes and crystal structure of Na2[Bi2(cit)2]·7H2O
  238. 1H NMR Studies of the Imidazole Complex of Cytochrome c: Resonance Assignment and Structural Characterization of the Heme Cavity
  239. Ranitidine bismuth(III) citrate
  240. NMR Investigation of the Aggregation Behavior of Diazafluorenone Schiff Base Amphiphile in CDCL3Solution
  241. Assignments of Nonexchangeable Proton Resonances and the Solution Structures of d–TGGGT
  242. Syntheses and Characterization of Coenzyme B12 Analogues Containing 2′-Deoxynucleosede
  243. Two Dimensional1HNMR Studies on 2′5′-Dideoxyadenosylcobalamin